Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

Actin vs MyStart Health

An in-depth comparison of two leading GLP-1 Providers

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

7.0

Actin

Best for affordable compounded semaglutide with B12 enhancement
★★★3.5

Starting at $133/mo

Compounded SemaglutideB12 Enhanced
Visit Actin
7.7

MyStart Health

Best for fastest compounded GLP-1 onboarding with a price lock
★★★3.9

Starting at $299/mo

CompoundedSemaglutideTirzepatidePrice Lock Guarantee
Visit MyStart Health

Side-by-Side Comparison

FeatureActinMyStart Health
Overall Score7.0/107.7/10
Starting Price$133/mo$299/mo
Editorial Rating3.5 ★ /53.9 ★ /5
Features2 features6 features
States Available00
Compounded✓ Yes✓ Yes
Brand Name
FSA/HSA Accepted
FDA WarningsNoneNone

Pros & Cons

Actin

Pros

  • Semaglutide + B12 combination for added energy support
  • Transparent pricing — exact cost shown upfront with no hidden fees
  • Competitive starting price from $133

Cons

  • Semaglutide only — no tirzepatide or liraglutide
  • No visible LegitScript or PCAB accreditation
  • State availability not disclosed
  • Broader platform (hormones, sexual wellness, hair health)

MyStart Health

Pros

  • Price Lock Guarantee — base monthly rate ($299) doesn't increase even when your prescribed dose escalates
  • Fast onboarding: quoted 5-minute intake, 24-hour prescription turnaround, 2–4 day shipping
  • 24/7 access to the care team with unlimited clinician messaging included
  • LegitScript certified
  • Transparent Section 503A compounding disclosure on every landing page

Cons

  • Not BBB accredited — BBB rating of C+ with 10 complaints filed against the business (BBB file opened April 24, 2025), most involving shipping delays and customer service access issues in early 2026
  • Compounded only — no FDA-approved Ozempic, Wegovy, Zepbound, or Mounjaro
  • Oral tirzepatide referenced in marketing but FAQ clarifies injectable is 'currently more common' — no FDA-approved oral tirzepatide exists, and the November 2025 Chimicles class action against OpenLoop/Triad Rx over unapproved oral tirzepatide products is a cautionary data point for the category
  • Very recent company (incorporated May 21, 2024 per BBB) — limited operational track record
  • Pharmacy partners not publicly named — no independent way to verify 503A compliance
  • Clinical efficacy claims are based on a homepage survey of only 16 self-reporting customers

Our Verdict

Winner: MyStart HealthScore: 7.7/10

MyStart Health edges out Actin with a higher overall score of 7.7/10 and is particularly strong for fastest compounded GLP-1 onboarding with a price lock. Actin remains a solid alternative, especially if you're looking for affordable compounded semaglutide with B12 enhancement.

Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.